Prostaglandin E2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP4 by Chun-Yang Xiao, Koh-ichi Yuhki, Akiyoshi Hara, Takayuki.

Slides:



Advertisements
Similar presentations
Involvement of the Mitochondrial Calcium Uniporter in Cardioprotection by Ischemic Preconditioning.
Advertisements

GLP-1 Effectiveness, Mechanisms of Action and Potential Part 4 of 4.
Yan Wu, Xiangru Lu, Fuli Xiang, and Qingping Feng
Date of download: 7/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Myocardial Edema as Detected by Pre-Contrast T1 and.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fibroblast growth factor-1 improves cardiac functional.
Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-α, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/Reperfusion.
Elastin Stabilizes an Infarct and Preserves Ventricular Function by Tomohiro Mizuno, Terrence M. Yau, Richard D. Weisel, Chris G. Kiani, and Ren- Ke Li.
Journal of Molecular and Cellular Cardiology
Cardioprotective Effect of a Hemoglobin-Based Oxygen Carrier on Cold Ischemia/Reperfusion Injury Cardiology 2011;120:73–83 - DOI: / Fig.
Arterioscler Thromb Vasc Biol
by Hideto Sano, Kohei Hosokawa, Hiroyasu Kidoya, and Nobuyuki Takakura
Soluble Tumor Necrosis Factor Receptor Abrogates Myocardial Inflammation but Not Hypertrophy in Cytokine-Induced Cardiomyopathy by Toru Kubota, George.
ΓδT Cell–Derived Interleukin-17A via an Interleukin-1β–Dependent Mechanism Mediates Cardiac Injury and Fibrosis in HypertensionNovelty and Significance.
Circ Cardiovasc Interv
by Johannes B. K. Schwarz, Nicolas Langwieser, Nicole N
Vascular PPARδ Protects Against Stroke-Induced Brain Injury
Involvement of Wnt Signaling in Dermal Fibroblasts
Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury by Wenjie Wang, Costas J. Schulze, Wilma.
Vascular Progenitor Cells in Diabetes Mellitus
Arterioscler Thromb Vasc Biol
Dapper-1 Induces Myocardial Remodeling Through Activation of Canonical Wnt Signaling in CardiomyocytesNovelty and Significance by Marco Hagenmueller, Johannes.
Mice Lacking the Vascular Endothelial Growth Factor-B Gene (Vegfb) Have Smaller Hearts, Dysfunctional Coronary Vasculature, and Impaired Recovery From.
Arterioscler Thromb Vasc Biol
Correction for vol. 41, p. 156 Hypertension Volume 43(2):e9-e9
Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin by Christian M. Matter, Pia K. Schuler, Patrizia.
Anti-CD40 and CpG induce activation of T cells in draining lymph nodes
Activation of Liver-X-Receptor α But Not Liver-X-Receptor β Protects Against Myocardial Ischemia/Reperfusion InjuryCLINICAL PERSPECTIVE by Qing He, Jun.
β2-Adrenergic Agonists Suppress Rat Autoimmune Myocarditis
The Calcium Paradoxon of Renin Release
by José J. Fuster, Noriyuki Ouchi, Noyan Gokce, and Kenneth Walsh
Central role of Sp1-regulated CD39 in hypoxia/ischemia protection
by Koji Yamamoto, Vivian de Waard, Colleen Fearns, and David J
Simvastatin attenuates cardiac isograft ischemia-reperfusion injury by down-regulating CC chemokine receptor-2 expression  Rong Yin, MD, Jiaquan Zhu,
by Simon F. De Meyer, Alexander S. Savchenko, Michael S
Is hyperglycemia bad for the heart during acute ischemia?
Yasuyo Sano, Jin Mo Park  Journal of Investigative Dermatology 
Ryan M. McEnaney, MD, Ankur Shukla, MD, Michael C
Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia–reperfusion injury  Ashish K. Sharma, MBBS, Victor E.
Volume 91, Issue 2, Pages (February 2017)
Volume 63, Issue 1, Pages (January 2003)
Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac.
Long-term exposure to high altitude hypoxia during pregnancy increases fetal heart susceptibility to ischemia/reperfusion injury and cardiac dysfunction 
IL-1R1 Signaling Facilitates Munro’s Microabscess Formation in Psoriasiform Imiquimod-Induced Skin Inflammation  Mireia Uribe-Herranz, Li-Hua Lian, Kirsten.
Left ventricular unloading before reperfusion reduces endothelin-1 release and calcium overload in porcine myocardial infarction  Sophie Tamareille, PhD,
Proteasome Inhibition Attenuates Infarct Size and Preserves Cardiac Function in a Murine Model of Myocardial Ischemia-Reperfusion Injury  William E. Stansfield,
Jason A. Bartos et al. BTS 2016;j.jacbts
FGL2 prothrombinase contributes to the early stage of coronary microvascular obstruction through a fibrin-dependent pathway  Wen-Zhu Li, Yi Yang, Kun.
M2b macrophages reduce early reperfusion injury after myocardial ischemia in mice: A predominant role of inhibiting apoptosis via A20  Yuan Yue, Xiao.
Effects of cardioplegia on vascular function and the “no-reflow" phenomenon after ischemia and reperfusion: Studies in the isolated blood-perfused rat.
S100A15, an Antimicrobial Protein of the Skin: Regulation by E
Dandan Wang et al. BTS 2018;3: Cardiomyocyte-Specific Knock-In miR-24 Ameliorates Ischemia/Reperfusion Injury (A) Quantitative polymerase chain.
CD169+ macrophages mediate Lm translocation to the splenic T cell zones. CD169+ macrophages mediate Lm translocation to the splenic T cell zones. (A) Confocal.
Volume 9, Issue 5, Pages (May 2009)
Volume 120, Issue 2, Pages (February 2001)
Volume 6, Issue 1, Pages (July 2009)
by Christina U. Lorentz, Norah G
Volume 82, Issue 2, Pages (July 2012)
Volume 75, Issue 5, Pages (March 2009)
Volume 83, Issue 6, Pages (June 2013)
Ischemic preconditioning ameliorates spinal cord ischemia-reperfusion injury by triggering autoregulation  Cheng-Loong Liang, MD, Kang Lu, MD, PhD, Po-Chou.
Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation  Yutaka.
Volume 33, Issue 5, Pages (November 2010)
T cell–intrinsic prostaglandin E2-EP2/EP4 signaling is critical in pathogenic TH17 cell– driven inflammation  Jinju Lee, MSc, Tomohiro Aoki, MD, PhD, Dean.
Prostaglandin E receptor subtype EP3 in conjunctival epithelium regulates late-phase reaction of experimental allergic conjunctivitis  Mayumi Ueta, MD,
Prostaglandin E2–EP3 signaling suppresses skin inflammation in murine contact hypersensitivity  Tetsuya Honda, MD, PhD, Toshiyuki Matsuoka, MD, PhD, Mayumi.
Volume 19, Issue 6, Pages (May 2017)
Fig. 1 OVA-releasing scaffolds concentrate OVA-specific CD4+T cells following ischemic injury. OVA-releasing scaffolds concentrate OVA-specific CD4+T cells.
SY-1425 induces maturation in RARA-high AML
Fig. 6 Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9 in vivo. Antitumor effect on tumor growth and pulmonary metastasis of CSSD-9.
Volume 20, Issue 3, Pages (March 2012)
Presentation transcript:

Prostaglandin E2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP4 by Chun-Yang Xiao, Koh-ichi Yuhki, Akiyoshi Hara, Takayuki Fujino, Shuhko Kuriyama, Takehiro Yamada, Koji Takayama, Osamu Takahata, Hideji Karibe, Takanobu Taniguchi, Shuh Narumiya, and Fumitaka Ushikubi Circulation Volume 109(20):2462-2468 May 25, 2004 Copyright © American Heart Association, Inc. All rights reserved.

Figure 1. Murine ventricle expresses mRNAs for EPs Figure 1. Murine ventricle expresses mRNAs for EPs. A, RT-PCR showing expressions of mRNAs for EPs. B, Competitive RT-PCR showing expression levels of mRNAs for EP2, EP3, and EP4. n=3. Figure 1. Murine ventricle expresses mRNAs for EPs. A, RT-PCR showing expressions of mRNAs for EPs. B, Competitive RT-PCR showing expression levels of mRNAs for EP2, EP3, and EP4. n=3. Chun-Yang Xiao et al. Circulation. 2004;109:2462-2468 Copyright © American Heart Association, Inc. All rights reserved.

Figure 2. Infarct size in EP4−/− heart after I/R is larger than that in wild-type heart. Figure 2. Infarct size in EP4−/− heart after I/R is larger than that in wild-type heart. A, Representative photomicrographs of horizontal section of left ventricle from wild-type and EP4−/− mice after I/R. Tissue area stained blue represents nonischemic area. Within ischemic area, tissue area stained red is still alive, and tissue area appearing pale white is necrotic. B, Infarct size after I/R in wild-type (□) and EP4−/− (▪) mice. Infarct size and AAR as a percentage of AAR and LVS, respectively, are presented. *P<0.05 vs wild-type group. n=10. Chun-Yang Xiao et al. Circulation. 2004;109:2462-2468 Copyright © American Heart Association, Inc. All rights reserved.

Figure 3. Endogenous PGE2 exhibits cardioprotective effect against I/R injury in vitro. Figure 3. Endogenous PGE2 exhibits cardioprotective effect against I/R injury in vitro. A and B, Developed (A) and diastolic (B) tensions during reperfusion period. C, Release of CK into coronary flow during reperfusion period. D, Changes of coronary flow rate during reperfusion period. In A, B, and D, values are expressed as a percentage of respective preischemic value. ○, Wild-type hearts; •, EP4−/− hearts. *P<0.05 vs wild-type hearts. n=13. Chun-Yang Xiao et al. Circulation. 2004;109:2462-2468 Copyright © American Heart Association, Inc. All rights reserved.

Figure 4. Effects of AE1-329 on [cAMP]i in noncardiomyocytes (A) and cardiomyocytes (B). Figure 4. Effects of AE1-329 on [cAMP]i in noncardiomyocytes (A) and cardiomyocytes (B). A, Concentration-dependent stimulatory effect of AE1-329 on [cAMP]i in noncardiomyocytes from wild-type (○, n=4) and EP4−/− (•, n=3) mice. Error bars are hidden within symbols. B, Effect of AE1-329 on [cAMP]i in cardiomyocytes. Cells were incubated with vehicle (□, n=5 for wild-type group and n=4 for EP4−/− group) or 10 μmol/L of AE1-329 (▪, n=5 for wild-type group and n=4 for EP4−/− group). *P<0.05 vs control group. Chun-Yang Xiao et al. Circulation. 2004;109:2462-2468 Copyright © American Heart Association, Inc. All rights reserved.

Figure 5. An EP4 agonist decreases infarct size in vivo in wild-type but not in EP4−/− mice. Figure 5. An EP4 agonist decreases infarct size in vivo in wild-type but not in EP4−/− mice. Infarct size as a percentage of AAR is presented. □ indicates control group; , group injected with 4819-CD before ischemia; and ▪, group injected with 4819-CD after ischemia. *P<0.05 vs control group. †P<0.05 vs wild-type group. n=6 to 8. Chun-Yang Xiao et al. Circulation. 2004;109:2462-2468 Copyright © American Heart Association, Inc. All rights reserved.